Functional precision medicine (FPM), combining ex vivo drug sensitivity testing with genomic profiling to identify treatment options for recurrent/refractory cancer, is feasible and poised to accelerate. This forum explores the history of FPM, recent clinical advancements, and barriers to expanding the clinical utility and accessibility for pediatric/adolescent and adult cancers.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.molmed.2024.10.015 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!